Progress of KCE Trials funded studies
Every month, clinical studies funded by KCE Trials reach important milestones. The most recent ones are listed below.
This month marks significant progress across several funded studies, with seven key study milestones achieved! Three new contracts have been signed, launching the GPS-AD, the HIPRO and the PRECISE-2 trials. In addition, two studies, AWARE and Life-Twin, have both enrolled their first patient. We are also pleased to highlight the publication of results from two studies funded under our dedicated call on long covid: PURE COVID and COVCOG, further contributing to the dissemination of independent, publicly funded research.
Finally, we have released an updated version of the KCE Trials protocol templates, aligned with the latest version of the SPIRIT Statement, to support investigators in developing robust, transparent, and internationally compliant study protocols.
As a public funder, we are committed to full transparency. You can find a lot of information on all funded trials (70 so far) on our website and on our dynamic dashboard.
At the end of the year, we are grateful to all who support and conduct independent clinical research in the public interest.
The whole KCE Trials team wishes you a warm holiday season and look forward to continuing this collective effort to strengthen evidence-based care.
Website KCE Dashboard
|
Congratulations to the PURE-COVID (Pulmonary rehabilitation for Long COVID) study team for publication of the results ! |
|
Congratulations to the COV-COG (cognitive versus emotion management psychoeducation programs in covid patients with neuropsychological difficulties) study team for publication of the results ! |
|
The contract has been signed for the GPS-AD (General Practitioner and Pharmacist Support for Antidepressant Discontinuation). Dr Van Leeuwen from UGent is the chief investigator. |
|
The contract has been signed for the HIPRO study (thromboprophylaxis in critically ill patients). The chief investigator is Dr Labbe HUB (Erasme). |
|
The contract has been signed for the PRECISE-2 study (protein intake in patients in ICU). The chief investigator is Dr Mesotten from ZOL. |
|
The first participant has been recruited in Belgium in the AWARE study (prevention to recurrence of adhesive small bowel obstruction), funded under the BeNeFIT-3 call. |
|
The first participant has been recruited in the LIFETWIN pilot study (lifestyle intervention to improve twin pregnancy outcome). |
| Our two protocol templates (one for studies with IMP or MD, one for other studies) have been adapted to follow the last update of the SPIRIT statement. |
